Can Fite Biopharma Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Can Fite Biopharma Ltd - ADR
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
/ 
Frequently asked questions
To buy Can Fite Biopharma Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Can Fite Biopharma Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Can Fite Biopharma Ltd - ADR is CANF:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Can Fite Biopharma Ltd - ADR has its primary listing on NYSE American. You can trade Can Fite Biopharma Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Can Fite Biopharma Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Can Fite Biopharma Ltd - ADR as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Can Fite Biopharma Ltd - ADR.